AGIO
Price
$46.08
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
MNKD
Price
$6.82
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
7 days until earnings call
Ad is loading...

AGIO vs MNKD

Header iconAGIO vs MNKD Comparison
Open Charts AGIO vs MNKDBanner chart's image
Agios Pharmaceuticals
Price$46.08
Change-$0.00 (-0.00%)
Volume$503.06K
CapitalizationN/A
MannKind
Price$6.82
Change-$0.00 (-0.00%)
Volume$2.44M
CapitalizationN/A
View a ticker or compare two or three
AGIO vs MNKD Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AGIO vs. MNKD commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and MNKD is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (AGIO: $46.08 vs. MNKD: $6.83)
Brand notoriety: AGIO and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 89% vs. MNKD: 87%
Market capitalization -- AGIO: $2.59B vs. MNKD: $1.7B
AGIO [@Biotechnology] is valued at $2.59B. MNKD’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 1 green, 4 red.
According to our system of comparison, MNKD is a better buy in the long-term than AGIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 6 TA indicator(s) are bullish while MNKD’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 6 bullish, 3 bearish.
  • MNKD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than MNKD.

Price Growth

AGIO (@Biotechnology) experienced а +0.92% price change this week, while MNKD (@Biotechnology) price change was +3.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

AGIO is expected to report earnings on Feb 13, 2025.

MNKD is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.6B) has a higher market cap than MNKD($1.71B). AGIO YTD gains are higher at: 106.915 vs. MNKD (87.637). MNKD has higher annual earnings (EBITDA): 53.3M vs. AGIO (-399.1M). AGIO has more cash in the bank: 570M vs. MNKD (248M). AGIO has less debt than MNKD: AGIO (64.6M) vs MNKD (231M). MNKD has higher revenues than AGIO: MNKD (248M) vs AGIO (31.3M).
AGIOMNKDAGIO / MNKD
Capitalization2.6B1.71B152%
EBITDA-399.1M53.3M-749%
Gain YTD106.91587.637122%
P/E RatioN/A125.70-
Revenue31.3M248M13%
Total Cash570M248M230%
Total Debt64.6M231M28%
FUNDAMENTALS RATINGS
AGIO vs MNKD: Fundamental Ratings
AGIO
MNKD
OUTLOOK RATING
1..100
419
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
7119
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4140
P/E GROWTH RATING
1..100
10048
SEASONALITY SCORE
1..100
5028

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (55) in the Biotechnology industry is in the same range as MNKD (82). This means that AGIO’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Profit vs Risk Rating (19) in the Biotechnology industry is somewhat better than the same rating for AGIO (71). This means that MNKD’s stock grew somewhat faster than AGIO’s over the last 12 months.

AGIO's SMR Rating (96) in the Biotechnology industry is in the same range as MNKD (100). This means that AGIO’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's Price Growth Rating (40) in the Biotechnology industry is in the same range as AGIO (41). This means that MNKD’s stock grew similarly to AGIO’s over the last 12 months.

MNKD's P/E Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for AGIO (100). This means that MNKD’s stock grew somewhat faster than AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOMNKD
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 7 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 6 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
+4.43%
NTLA - MNKD
49%
Loosely correlated
+2.45%
PGEN - MNKD
44%
Loosely correlated
-0.61%
QSI - MNKD
44%
Loosely correlated
+3.34%
VCYT - MNKD
44%
Loosely correlated
+3.30%
INZY - MNKD
43%
Loosely correlated
-0.21%
More